Thompson Davis & Co’s CervoMed CRVO Stock Holding History

Thompson Davis & Co’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92.2K	Buy	29,750 +19,750	+198%	+$69.6K	0.06%	154
2026 Q1	$39.4K	Hold	10,000	–	–	0.03%	138
2025 Q4	$79K	Sell	10,000 -6,850	-41%	-$55K	0.05%	138
2025 Q3	$136K	Buy	16,850 +2,900	+21%	+$24.9K	0.08%	127
2025 Q2	$87.7K	Buy	+13,950	New	+$119K	0.06%	117

Other funds holding CRVO

BAM

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $774M AUM 27.34% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Thompson Davis & Co's CRVO Position: Q2 2026 in Review

Thompson Davis & Co increased its CervoMed (CRVO) stake by 198% in Q2 2026, buying an estimated $69.6K and bringing the position to 29,750 shares worth $92.2K. The position accounts for 0.06% of the portfolio, ranked #154.

Thompson Davis & Co first reported a position in CRVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $136K in Q3 2025. 5 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

Thompson Davis & Co held 29,750 shares of CervoMed worth $92.2K as of Q2 2026.
Thompson Davis & Co bought 19,750 CervoMed shares in Q2 2026, an estimated $69.6K.
CervoMed made up 0.06% of Thompson Davis & Co's portfolio in Q2 2026, its #154 holding.
Thompson Davis & Co first reported a position in CervoMed in Q2 2025 and has held it in 5 quarters since.
Thompson Davis & Co's CervoMed position peaked at $136K in Q3 2025.
5 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Thompson Davis & Co's 13F filing for Q2 2026, filed 29 Jul 2026.